ICAP appoints Ivan Ritossa to the Board as a Non-Executive Director

by

LONDON – ICAP plc (IAP.L), a leading markets operator and provider of post trade risk mitigation and information services, today announces that, following the announcement of board changes on 7 June 2013 and the annual general meeting held earlier today, Ivan Ritossa was appointed as a non-executive director of the Company. He has also been appointed to the Remuneration and Risk Committees.

Ivan Ritossa joined Barclays in 2002 as global head of foreign exchange in London and later relocated to Singapore. In 2007, he assumed additional responsibility as head of global markets Asia Pacific, and prime services in 2008. He was appointed deputy head of FICC in September 2010, and took on his most recent role in June 2011 as head of Latin America, Central and Eastern Europe, the Middle East and Africa for the Investment Bank at Barclays.

Prior to joining Barclays in 2002, Ivan Ritossa was co-global head of foreign exchange at Lehman Brothers in London. He joined Lehman Brothers in 1999 as head of European foreign exchange, having previously been global head of foreign exchange at Bankers Trust.

About ICAP

ICAP is a leading markets operator and provider of post trade risk mitigation and information services. The Group matches buyers and sellers in the wholesale markets in interest rates, credit, commodities, FX, emerging markets and equity derivatives through voice and electronic networks. Through its post trade risk mitigation and information services ICAP helps customers manage and mitigate risks in their portfolios.

Related articles
  • ICAP Says First-Quarter Revenue Rises on Volatility

- Disclaimer - News, data, and statements included in this release are intended exclusively for general information purposes. Talent4Boards does not guarantee that news is accurate or about the correct person and accepts neither liability for the consequences of the reader’s reliance, nor responsibility for the accuracy of the information. Nothing in this release should be considered for decisions about referred securities. Products and brand names may be trademarks or registered trademarks of their respective owners.

Related Posts: